Research Article
Seroprevalence against Rickettsia and Borrelia Species in Patients with Uveitis: A Prospective Survey
Table 1
Results of serology for the Rickettsia spp. in serum S1–S5 and Borrelia spp. in S2 for all patients diagnosed with uveitis.
| Group | Pat. number | Gender/age | S1 | Weeks | S2 | Weeks | S3 | Weeks | S4 | Weeks | S5 | Borrelia/s (S2) IgG/IgM | IgG | IgM | S1–S2 | IgG | IgM | S1-S3 | IgG | IgM | S1-S4 | IgG | IgM | S1-S5 | IgG | IgM |
| 1 | 1 | M/64 | 64 | <64 | 5 | 512 | 64 | 17 | 256 | <64 | | | | | | | Pos/border | 2 | M/41 | <64 | 64 | 14 | 128 | 256 | 45 | 64 | 128 | | | | | | | Neg/neg | 3 | F/13 | <64 | 128 | 5 | <64 | 512 | 10 | 256 | 512 | 26 | 512 | 1024 | 51 | 128 | 256 | Neg/neg | 4 | F/51 | <64 | 512 | 4 | 128 | 128 | 17 | 128 | <64 | | | | | | | Neg/neg | 5 | F/72 | 64 | 64 | 4 | 256 | 128 | 20 | 128 | <64 | | | | | | | Neg/neg | 6 | M/69 | <64 | <64 | 8 | 256 | <64 | 20 | 256 | <64 | 32 | 128 | <64 | | | | Neg/neg | 7 | F/43 | 64 | 512 | 6 | 256 | 1024 | 22 | 256 | 256 | | | | | | | Neg/neg |
| 2 | 8 | F/69 | 512 | 512 | 5 | 512 | 512 | 20 | 128 | 64 | | | | | | | Neg/neg | 9 | M/65 | 512 | 512 | 5 | 512 | 512 | 19 | 1024 | 2048 | 34 | 256 | 256 | | | | Neg/neg | 10 | M/39 | 128 | 64 | 9 | 64 | <64 | 16 | 256 | 512 | 33 | 64 | 128 | | | | Neg/neg | 11 | F/66 | 1024 | 1024 | 5 | 1024 | 2048 | 19 | 512 | 512 | 33 | 256 | 256 | | | | Neg/neg | 12 | M/66 | 512 | 256 | 4 | 1024 | 128 | 24 | 256 | 256 | | | | | | | Neg/neg | 13 | M/52 | 128 | 256 | 12 | 256 | 512 | 27 | 128 | 512 | 48 | 128 | 128 | | | | Border/neg | 14 | F/60 | 256 | 512 | 5 | 256 | 128 | 22 | 256 | 128 | 32 | 256 | 128 | | | | Neg/neg | 15 | M/58 | 128 | <64 | 5 | 256 | <64 | 21 | <64 | <64 | | | | | | | Neg/neg | 16 | M/50 | 256 | <64 | 11 | 64 | <64 | | | | | | | | | | Neg/pos | 17 | M/37 | 256 | 256 | 6 | 128 | 128 | 18 | 128 | 128 | | | | | | | Neg/neg | 18 | F/59 | 128 | <64 | 7 | 256 | <64 | 25 | 128 | <64 | | | | | | | Pos/neg | 19 | F/38 | 256 | 256 | 11 | 512 | 256 | | | | | | | | | | Neg/neg |
| 3 | 20 | F/77 | 64 | <64 | 5 | 64 | <64 | | | | | | | | | | Neg/pos | 21 | M/55 | 64 | <64 | 6 | 64 | <64 | | | | | | | | | | Neg/neg | 22 | M/48 | 64 | <64 | 6 | 128 | <64 | 19 | 64 | <64 | | | | | | | Neg/neg | 23 | F/68 | <64 | 128 | 5 | <64 | <64 | | | | | | | | | | Neg/neg | 24 | M/71 | 128 | 128 | 4 | 128 | 64 | 23 | 64 | <64 | | | | | | | Neg/neg | 25 | M/26 | 64 | <64 | 12 | 64 | <64 | | | | | | | | | | Neg/neg | 26 | F/52 | 128 | 512 | 12 | 128 | 64 | 34 | 64 | <64 | | | | | | | Neg/neg | 27 | M/38 | 64 | <64 | 5 | 128 | 64 | 21 | <64 | <64 | | | | | | | Neg/neg | 28 | F/63 | 64 | <64 | 6 | 64 | <64 | | | | | | | | | | Neg/pos | 29 | F/44 | 64 | 64 | 5 | <64 | 64 | | | | | | | | | | Border/neg | 30 | M/67 | 128 | <64 | 4 | 64 | <64 | | | | | | | | | | Pos/neg | 31 | F/25 | 64 | <64 | 7 | 64 | <64 | | | | | | | | | | Neg/neg | 32 | M/42 | 64 | <64 | 7 | 64 | <64 | | | | | | | | | | Neg/neg | 33 | M/62 | 128 | 64 | 17 | 64 | <64 | | | | | | | | | | Neg/neg | 34 | F/18 | <64 | <64 | 5 | 64 | 64 | | | | | | | | | | Neg/neg | 35 | F/54 | 128 | 128 | 9 | 64 | 128 | 14 | 128 | 128 | | | | | | | Neg/neg |
| 4 | 36 | M/72 | <64 | <64 | 9 | <64 | <64 | | | | | | | | | | Neg/neg | 37 | F/65 | <64 | <64 | 10 | <64 | <64 | | | | | | | | | | Neg/neg | 38 | M/27 | <64 | <64 | 5 | <64 | <64 | | | | | | | | | | Neg/neg | 39 | M/47 | <64 | <64 | 5 | <64 | <64 | | | | | | | | | | Neg/neg | 40 | M/70 | <64 | <64 | 4 | <64 | <64 | | | | | | | | | | Neg/neg | 41 | F/58 | <64 | <64 | 6 | <64 | <64 | | | | | | | | | | Neg/neg | 42 | F/53 | <64 | <64 | 6 | <64 | <64 | | | | | | | | | | Neg/neg | 43 | M/64 | <64 | <64 | 10 | <64 | <64 | | | | | | | | | | Neg/neg | 44 | M/53 | <64 | <64 | 27 | <64 | <64 | | | | | | | | | | Neg/neg | 45 | M/60 | <64 | <64 | 4 | <64 | <64 | | | | | | | | | | Neg/neg | 46 | M/53 | <64 | <64 | 5 | <64 | <64 | | | | | | | | | | Neg/neg | 47 | M/33 | <64 | <64 | 6 | <64 | <64 | | | | | | | | | | Neg/neg | 48 | M/47 | <64 | <64 | 6 | <64 | <64 | | | | | | | | | | Neg/neg |
|
|
Pat. number: patient number; M: male; F: female; S1–S5: serum samples 1–5.
|